DE602007004849D1 - Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie - Google Patents

Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie

Info

Publication number
DE602007004849D1
DE602007004849D1 DE602007004849T DE602007004849T DE602007004849D1 DE 602007004849 D1 DE602007004849 D1 DE 602007004849D1 DE 602007004849 T DE602007004849 T DE 602007004849T DE 602007004849 T DE602007004849 T DE 602007004849T DE 602007004849 D1 DE602007004849 D1 DE 602007004849D1
Authority
DE
Germany
Prior art keywords
allopurinol
treatment
sthesia
palmarer
erythrodysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007004849T
Other languages
English (en)
Inventor
Yolanda Rodemer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nobera Pharma SL
Original Assignee
Nobera Pharma SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06011432A external-priority patent/EP1862166A1/de
Application filed by Nobera Pharma SL filed Critical Nobera Pharma SL
Publication of DE602007004849D1 publication Critical patent/DE602007004849D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
DE602007004849T 2006-06-01 2007-05-31 Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie Active DE602007004849D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06011432A EP1862166A1 (de) 2006-06-01 2006-06-01 Verwendung von Allopurinol zur behandlung von palmar-plantarer Erythrodysesthesie
EP07107744 2007-05-08
PCT/EP2007/055367 WO2007138103A1 (en) 2006-06-01 2007-05-31 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia

Publications (1)

Publication Number Publication Date
DE602007004849D1 true DE602007004849D1 (de) 2010-04-01

Family

ID=38512579

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007004849T Active DE602007004849D1 (de) 2006-06-01 2007-05-31 Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie

Country Status (21)

Country Link
US (3) US7973046B2 (de)
EP (1) EP2035006B1 (de)
JP (3) JP5028480B2 (de)
KR (1) KR101471022B1 (de)
AT (1) ATE457729T1 (de)
AU (1) AU2007267069B2 (de)
CA (1) CA2654270C (de)
CY (1) CY1110336T1 (de)
DE (1) DE602007004849D1 (de)
DK (1) DK2035006T3 (de)
ES (1) ES2341379T3 (de)
HR (1) HRP20100210T1 (de)
IL (1) IL195472A (de)
MX (1) MX2008015266A (de)
NZ (1) NZ573248A (de)
PL (1) PL2035006T3 (de)
PT (1) PT2035006E (de)
RS (1) RS51252B (de)
RU (1) RU2438673C2 (de)
SI (1) SI2035006T1 (de)
WO (1) WO2007138103A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246057A1 (de) * 2009-04-29 2010-11-03 Nobera Pharma, S.L. Verwendung von Allopurinol zur Behandlung der Hand-Fuß-Hautreaktion
CN102648279B (zh) 2009-10-16 2015-11-25 杜克大学 用于治疗药物诱发的手足综合征的组合物与方法
EP2368549A1 (de) 2010-03-25 2011-09-28 BioAlliance Pharma Behandlung des Hand-Fuß-Syndroms und zugehöriger Symptome mittels Clonidin oder Derivaten davon
JP4983989B2 (ja) * 2010-03-31 2012-07-25 小野薬品工業株式会社 手足症候群の予防および治療剤
US8729056B2 (en) 2010-03-31 2014-05-20 Ono Pharmaceutical Co., Ltd. Preventive and/or therapeutic agent of hand-foot syndrome
JP4761000B1 (ja) * 2010-11-08 2011-08-31 小野薬品工業株式会社 手足症候群の予防および／または治療剤
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
EP2712613B1 (de) * 2012-09-28 2017-02-08 Pharmadab d.o.o. Vitamin K1 und Verwendungen davon
JP2019512536A (ja) * 2016-03-28 2019-05-16 ヴィダック ファーマ リミテッド 局所投与のための安定な医薬組成物およびその使用
WO2019114705A1 (zh) 2017-12-13 2019-06-20 上海小午医药科技有限公司 一种用于预防或治疗与egfr被抑制相关疾病的方法
KR20200144116A (ko) 2018-04-16 2020-12-28 온퀄리티 파마슈티컬스 차이나 리미티드 암 치료의 부작용을 예방하거나 치료하기 위한 방법
RU2722396C2 (ru) * 2018-07-11 2020-05-29 Федеральное государственное бюджетное учреждение дополнительного профессионального образования "Центральная государственная медицинская академия" Управления делами Президента Российской Федерации (ФГБУ ДПО "ЦГМА") Способ лечения пальмарно-плантарной эритродизестезии

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3011A (en) * 1843-03-21 Improvement in water-wheels
ES2037672T3 (es) 1987-02-13 1993-07-01 Pharm-Allergan Gmbh Utilizacion de pteridinas y/o purinas o de un inhibidor de xantinoxidasa para la fabricacion de un medicamento para el tratamiento de enfermedades degenerativas de la retina condicionadas geneticamente.
JPH03106817A (ja) 1989-09-20 1991-05-07 Nippon Kayaku Co Ltd アロプリノール製剤
JPH066700A (ja) 1992-06-22 1994-01-14 Fujitsu General Ltd ハイビジョン受像機
GB9218711D0 (en) 1992-09-04 1992-10-21 Salim Aws S M Skin cancer treatment
WO1994005293A1 (en) 1992-09-04 1994-03-17 Aws Shakir Mustafa Salim Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
JP3106817B2 (ja) 1993-11-02 2000-11-06 富士電機株式会社 漏電遮断器
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6060083A (en) 1999-04-01 2000-05-09 Topical Technologies, Inc. Topical DMSO treatment for palmar-plantar erythrodysethesia
EP1292265B1 (de) * 2000-06-20 2007-03-21 Henkel Kommanditgesellschaft auf Aktien Verwendung von Vitamin B6-Derivaten zur Haarstrukturverbesserung
DE60117043T2 (de) 2000-11-22 2006-07-13 Rxkinetix, Inc., Louisville Behandlung von mukositis
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
DK1455888T3 (da) * 2001-08-29 2009-08-24 Pharmakodex Ltd Topisk indgivelsesindretning
US20030157191A1 (en) 2001-11-29 2003-08-21 Sound Pharmaceuticals Incorporated Methods and compositions for ameliorating the undesirable effects of chemotherapy
DE10200578A1 (de) * 2002-01-09 2003-07-10 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme
US6979688B2 (en) * 2002-02-12 2005-12-27 Ford John P Treatment method against side-effects of chemotherapy
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
CA2528359A1 (en) 2003-06-11 2004-12-23 Novacea, Inc. Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
AU2004247108A1 (en) 2003-06-11 2004-12-23 Novacea, Inc Treatment of immune-mediated disorders with active vitamin D compounds alone or in combination with other therapeutic agents
US20050148910A1 (en) 2003-12-24 2005-07-07 Gregory Skover Apparatus having a skin-contactable element containing an agent
AU2005218539A1 (en) * 2004-03-01 2005-09-15 Lumen Therapeutics, Llc Compositions and methods for treating diseases
JP4405326B2 (ja) 2004-06-28 2010-01-27 株式会社東芝 ランドリー機器
WO2006030437A2 (en) * 2004-09-17 2006-03-23 Biomas Ltd. Novel tellurium compounds and their use as immunomodulators

Also Published As

Publication number Publication date
JP5389980B2 (ja) 2014-01-15
US7973046B2 (en) 2011-07-05
US20140011820A1 (en) 2014-01-09
JP2009542581A (ja) 2009-12-03
RS51252B (sr) 2010-12-31
PT2035006E (pt) 2010-04-22
DK2035006T3 (da) 2010-04-19
US8557829B2 (en) 2013-10-15
EP2035006B1 (de) 2010-02-17
IL195472A (en) 2012-04-30
PL2035006T3 (pl) 2010-07-30
SI2035006T1 (sl) 2010-04-30
CA2654270C (en) 2014-05-13
HRP20100210T1 (hr) 2010-05-31
US20090306097A1 (en) 2009-12-10
RU2438673C2 (ru) 2012-01-10
RU2008152341A (ru) 2010-07-20
JP2012180370A (ja) 2012-09-20
AU2007267069B2 (en) 2011-08-11
CY1110336T1 (el) 2015-01-14
IL195472A0 (en) 2011-08-01
JP5028480B2 (ja) 2012-09-19
WO2007138103A1 (en) 2007-12-06
ATE457729T1 (de) 2010-03-15
CA2654270A1 (en) 2007-12-06
KR20090031697A (ko) 2009-03-27
NZ573248A (en) 2011-01-28
ES2341379T3 (es) 2010-06-18
US20110224237A1 (en) 2011-09-15
EP2035006A1 (de) 2009-03-18
AU2007267069A1 (en) 2007-12-06
MX2008015266A (es) 2009-02-10
KR101471022B1 (ko) 2014-12-09
JP2014028851A (ja) 2014-02-13

Similar Documents

Publication Publication Date Title
ATE457729T1 (de) Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie
EA202091303A3 (ru) Композиция ингибитора jak для местного применения
ECSP13012618A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
EA200802223A1 (ru) 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90
DE602005013793D1 (de) Thiazolderivate mit vap-1-hemmender wirkung
MX2015013275A (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevencion de enfermedades o afecciones asociadas con difucion mitocondrial.
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
ATE541567T1 (de) Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten
WO2006108679A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use to combat cancer
CR10410A (es) Carboxamidas sustituidas.
MX2013002208A (es) Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
ATE420089T1 (de) Substituierte azachinazoline mit antiviraler wirkung
NO20075199L (no) Treatment or prevention of pruritus
RS53005B (en) APPLICATION OF ALOPURINOL FOR TREATMENT OF SKIN AND FOOTS
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
WO2007144889A3 (en) Treatment of neurofibromatosis
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
ATE546137T1 (de) Pharmazeutische zusammensetzungen zur behandlung von warzen
EA200970292A1 (ru) Производные 5-тиоксилопиранозы и их применение в терапии
EA200970293A1 (ru) Новые производные 5-тиоксилопиранозы
CY1114601T1 (el) Χρηση της αλλοπουρινολης για την αγωγη της δερματικης αντιδρασης χειρος-ποδος

Legal Events

Date Code Title Description
8364 No opposition during term of opposition